Maccallini MT - Search Results

1

Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin.

Ceddia S, Onesti CE, Vari S, Torchia A, Cosimati A, Riva F, Maccallini MT, Cerro M, Benvenuti G, Russillo M, Anelli V, Sperduti I, Biagini R, Ferraresi V. Ceddia S, et al. Among authors: maccallini mt. Front Pharmacol. 2024 Aug 20;15:1411707. doi: 10.3389/fphar.2024.1411707. eCollection 2024. Front Pharmacol. 2024. PMID: 39228518 Free PMC article.

2

Biobanks as an Indispensable Tool in the "Era" of Precision Medicine: Key Role in the Management of Complex Diseases, Such as Melanoma.

Valenti A, Falcone I, Valenti F, Ricciardi E, Di Martino S, Maccallini MT, Cerro M, Desiderio F, Miseo L, Russillo M, Guerrisi A. Valenti A, et al. Among authors: maccallini mt. J Pers Med. 2024 Jul 6;14(7):731. doi: 10.3390/jpm14070731. J Pers Med. 2024. PMID: 39063985 Free PMC article. Review.

3

[Dramatic response to encorafenib plus binimetinib in a patient with leukemoid reaction from metastatic melanoma.].

Cerro M, Maccallini MT, Russillo M. Cerro M, et al. Among authors: maccallini mt. Recenti Prog Med. 2024 May;115(5):13e-16e. doi: 10.1701/4262.42409. Recenti Prog Med. 2024. PMID: 38708541 Italian.

4

Artificial Intelligence and Advanced Melanoma: Treatment Management Implications.

Guerrisi A, Falcone I, Valenti F, Rao M, Gallo E, Ungania S, Maccallini MT, Fanciulli M, Frascione P, Morrone A, Caterino M. Guerrisi A, et al. Among authors: maccallini mt. Cells. 2022 Dec 8;11(24):3965. doi: 10.3390/cells11243965. Cells. 2022. PMID: 36552729 Free PMC article. Review.

5

Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!

Di Noia V, Pimpinelli F, Renna D, Maccallini MT, Gariazzo L, Cosimati A, Campo F, Sperandio E, Pellini R, Giannarelli D, Cognetti F. Di Noia V, et al. Among authors: maccallini mt. Eur J Cancer. 2022 Apr;165:169-173. doi: 10.1016/j.ejca.2022.01.011. Epub 2022 Mar 1. Eur J Cancer. 2022. PMID: 35245863

6

Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer.

Di Noia V, Pimpinelli F, Renna D, Maccallini MT, Gariazzo L, Riva F, Sperandio E, Giannarelli D, Cognetti F. Di Noia V, et al. Among authors: maccallini mt. Ann Oncol. 2022 May;33(5):563-565. doi: 10.1016/j.annonc.2022.02.006. Epub 2022 Feb 22. Ann Oncol. 2022. PMID: 35202794 Free PMC article. No abstract available.

7

Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution.

Di Noia V, Pimpinelli F, Renna D, Barberi V, Maccallini MT, Gariazzo L, Pontone M, Monti A, Campo F, Taraborelli E, Di Santo M, Petrone F, Mandoj C, Ferraresi V, Ferretti G, Carlini P, Di Bella O, Conti L, La Malfa AM, Pellini R, Bracco D, Giannarelli D, Morrone A, Cognetti F. Di Noia V, et al. Among authors: maccallini mt. Clin Cancer Res. 2021 Dec 15;27(24):6815-6823. doi: 10.1158/1078-0432.CCR-21-2439. Epub 2021 Sep 28. Clin Cancer Res. 2021. PMID: 34583970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters